Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.25.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Shares
Redeemable Convertible
Preferred Shares
Redeemable Convertible
Common Stock
Additional paid in capital
Accumulated deficit
Total
Balance at Dec. 31, 2023 $ 3 $ 166,048 $ (162,970) $ 3,081
Balance (in Shares) at Dec. 31, 2023     4,723,380      
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost [1] $ 12,561   $ 1 3,227 3,228
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost (in Shares) [1] 40,470   916,497      
Exercise of Pre-Funded Warrants into shares of Common Stock [1]     [2] 5 5
Exercise of Pre-Funded Warrants into shares of Common Stock (in Shares) [1]     477,827      
Issuance of Common Stock under At the Market Sales Agreement, net of $1 issuance costs [1]     [2] 19 19
Issuance of Common Stock under At the Market Sales Agreement, net of $1 issuance costs (in Shares) [1]     7,518      
Stock-based compensation expenses     909 909
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs [1] $ 19,859   541   541
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs (in Shares) [1] 216,417        
Net Income (loss)       (17,327) (17,327)
Balance at Mar. 31, 2024 $ 32,420 $ 4 170,749 (180,297) (9,544)
Balance (in Shares) at Mar. 31, 2024 256,887   6,125,222      
Balance at Dec. 31, 2023 $ 3 166,048 (162,970) 3,081
Balance (in Shares) at Dec. 31, 2023     4,723,380      
Net Income (loss)           (12,856)
Balance at Jun. 30, 2024   $ 32,420 $ 5 170,826 (175,826) 27,425
Balance (in Shares) at Jun. 30, 2024   256,887 7,106,033      
Balance at Mar. 31, 2024 $ 32,420 $ 4 170,749 (180,297) (9,544)
Balance (in Shares) at Mar. 31, 2024 256,887   6,125,222      
Exercise of Pre-Funded Warrants into shares of Common Stock [1]     $ 1 1
Exercise of Pre-Funded Warrants into shares of Common Stock (in Shares) [1]     980,811      
Reclassification of Redeemable Convertible Preferred Shares to equity $ (32,420) $ 32,420 32,420
Reclassification of Redeemable Convertible Preferred Shares to equity (in Shares) (256,887) 256,887        
Stock-based compensation expenses     77 77
Net Income (loss)   4,471 4,471
Balance at Jun. 30, 2024   $ 32,420 $ 5 170,826 (175,826) 27,425
Balance (in Shares) at Jun. 30, 2024   256,887 7,106,033      
Balance at Dec. 31, 2024 $ 18,645   $ 6 186,194 (180,697) 24,148
Balance (in Shares) at Dec. 31, 2024 147,735   18,176,661      
Issuance of Common Stock, Registered Pre-Funded Warrants and Private Pre-Funded Warrants under the February 2025 SPA, net of issuance costs [1]     [2] 878   878
Issuance of Common Stock, Registered Pre-Funded Warrants and Private Pre-Funded Warrants under the February 2025 SPA, net of issuance costs (in Shares) [1]     2,828,283      
Issuance of Common Stock under Inducement Letter Agreements [1]     $ 1 6,472   6,473
Issuance of Common Stock under Inducement Letter Agreements (in Shares) [1]     3,961,109      
Stock-based compensation expenses       659   659
Net Income (loss)     (7,659) (7,659)
Balance at Mar. 31, 2025 $ 18,645   $ 7 194,203 (188,356) 24,499
Balance (in Shares) at Mar. 31, 2025 147,735   24,966,053      
Balance at Dec. 31, 2024 $ 18,645   $ 6 186,194 (180,697) 24,148
Balance (in Shares) at Dec. 31, 2024 147,735   18,176,661      
Net Income (loss)           (13,696)
Balance at Jun. 30, 2025 $ 18,645   $ 7 194,901 (194,393) 19,160
Balance (in Shares) at Jun. 30, 2025 147,735   26,443,257      
Balance at Mar. 31, 2025 $ 18,645   $ 7 194,203 (188,356) 24,499
Balance (in Shares) at Mar. 31, 2025 147,735   24,966,053      
Exercise of Private Pre-Funded Warrants and Common Warrants [1]     [2] 2 2
Exercise of Private Pre-Funded Warrants and Common Warrants (in Shares) [1]     1,202,314      
Issuance of Common Stock upon restricted stock units vesting [3]     [2] [2]
Issuance of Common Stock upon restricted stock units vesting (in Shares) [3]     274,890      
Stock-based compensation expenses       696   696
Net Income (loss)         (6,037) (6,037)
Balance at Jun. 30, 2025 $ 18,645   $ 7 $ 194,901 $ (194,393) $ 19,160
Balance (in Shares) at Jun. 30, 2025 147,735   26,443,257      
[1] See Note 9A.
[2] Less than $1.
[3] See Note 9B.